SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...

When added to optimized oral anti-lipid therapy, a PCSK9 blocker provided an additional 25% risk reduction in a first ...

Finerenone shows significant benefits in patients with kidney disease and type 1 diabetes, which could lead to the first ...

Given prior negative studies of fish oil supplements for CV prevention, the positive findings for PISCES in patients on ...

Substantial reductions in adverse cardiovascular outcomes are especially notable for this high-risk population, but ...

A higher-titer ANA raises the suspicion that something more systemic may be going on,’ said Amanda Mixon, PA-C.

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers ...

In the absence of FDA-approved long COVID treatments, desperate patients look to alternative medicine. Here’s a look at what ...

Experts explore the messy intersection between evidence-based cancer care and an enticing wellness industry dominated by ...

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...

Vague symptoms. Crazy blood pressure. Fruitless ER visits. Then suddenly, this doctor had stage IV cancer. Or maybe not. Her ...

With greater understanding of the complex pathomechanisms of myalgic encephalomyelitis/chronic fatigue syndrome, researchers ...